CAH vs COR
Cardinal Health (CAH) and Cencora (COR) compared side by side. Cencora (COR) is larger, with a market cap of $63.2B versus $57.8B for Cardinal Health, about 1.1 times the size. On trailing earnings, COR is cheaper at 24.6x versus 34.5x for CAH.
Head to head
| Metric | CAH | COR |
|---|---|---|
| Market cap | $57.8B | $63.2B |
| P/E (TTM) | 34.5x | 24.6x |
| Forward P/E | 17.8x | 16.7x |
| Revenue (TTM) | $254.2B | $332.8B |
| Revenue growth | 5.8% | 5.1% |
| Gross margin | 3.8% | 4.0% |
| Operating margin | 1.3% | 1.4% |
| Free cash flow | $4.5B | $4.1B |
| Dividend yield | 0.83% | 0.73% |
| 1-year return | +58.3% | +1.5% |
| 5-year return (annual) | +41.0% | +23.3% |
| Max drawdown | -62% | -71% |
| FI Handbook grade | C | C |
Highlighted: the stronger figure on metrics where higher or lower is clearly better.
Growth of $10,000 (5 years, price only)
CAH vs COR FAQ
Which is bigger, CAH or COR?
Cencora (COR) is larger, with a market cap of $63.2B versus $57.8B for Cardinal Health, about 1.1 times the size.
Is CAH or COR cheaper?
On trailing earnings, COR is cheaper at 24.6x versus 34.5x for CAH. A lower P/E can reflect slower expected growth, so compare growth and margins too.
Which stock performed better over the past year, CAH or COR?
CAH returned +58.3% over the past year including dividends, versus +1.5% for COR, through October 23, 2026.
Which pays a higher dividend, CAH or COR?
CAH yields 0.83% versus 0.73% for COR.
Full pages: Cardinal Health · Cencora